Lotus Pharmaceuticals Inc (LTUS)

[BiotechValues]

Well, it's good that's it's getting off the ground a bit here.
But I'm buying this one for a longer ride so am not too concerned about short term movement up or down.

That said, there are a lot of catalysts for upward momentum that could come at any time now:

***A good earnings report (because I think a miss is priced in at these levels)where they meet or beat the $13.1M net income target.

***Final SFDA approval on one or more of the late stage development drugs they have in the pipeline.

***Final central government approval of their pharmaceutical park plans.

***Securing a government grant, low interest bank loan (collatoralized by the land rights they now have), rental or sale of the large chunk of land they won't be using, etc.

***Hiring of a new IR firm/attendance at a road show or two/etc.

Lots of good things to come, and to think entire market cap of the company is now priced at about the annual revenues generated by one drug they aquired last month.

42M shares x .25/share = $10.5M market cap.
Revenues from Yipubishan were $9.8M last year, and expected to be $75M RMB, or $10.5M in 2009 with 75% profit margins.

I just can't see this stock being priced under .30 much longer- especially if any of the above events happen soon.